{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:36:25Z","timestamp":1791905785599,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ijantimicag.2025.107553","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T01:10:43Z","timestamp":1750209043000},"page":"107553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Susceptibility to new antibiotics and genetic characterisation of carbapenemase-producing Enterobacterales: low activity of cefiderocol against NDM-producing isolates"],"prefix":"10.1016","volume":"66","author":[{"given":"Lisa","family":"Fax\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilhelm","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6558-1323","authenticated-orcid":false,"given":"Margarita","family":"Chatzopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Karlsson Lindsj\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernilla","family":"Lagerb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Westmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"\u00c5kerlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7142-9849","authenticated-orcid":false,"given":"Thomas","family":"T\u00e4ngd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0553-1391","authenticated-orcid":false,"given":"Inga","family":"Fr\u00f6ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107553_bib0001","doi-asserted-by":"crossref","first-page":"iv23","DOI":"10.1093\/jac\/dkab352","article-title":"Current and future perspectives in the treatment of multidrug-resistant gram-negative infections","volume":"76","author":"Bassetti","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0002","first-page":"271","article-title":"Pandrug-resistant gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options","volume":"75","author":"Karakonstantis","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106528","article-title":"Carbapenemase-producing Enterobacterales infections: recent advances in diagnosis and treatment","volume":"59","author":"Lee","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40121-020-00286-6","article-title":"Cefiderocol: A novel agent for the management of multidrug-resistant gram-negative organisms","volume":"9","author":"Wu","year":"2020","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0005","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. http:\/\/www.eucast.org (accessed 27 February 2024)."},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0006","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. EUCAST Disk Diffusion Method for Antimicrobial Susceptibility Testing, Version 11.0, January 2023, http:\/\/www.eucast.org (accessed 15 November 2024)."},{"key":"10.1016\/j.ijantimicag.2025.107553_bib48","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. EUCAST guidance document on cefiderocol BMD, January 2024, http:\/\/www.eucast.org (accessed 15 November 2024)."},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0007","unstructured":"M100 Ed34 | Performance Standards for Antimicrobial Susceptibility Testing, https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m100\/ (accessed 18 June 2024)."},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0008","first-page":"297","article-title":"Improving the genotyping resolution of cryptosporidium hominis subtype IbA10G2 using one step PCR-based amplicon sequencing","volume":"55","author":"Beser","year":"2017","journal-title":"Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0009","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinforma Oxf Engl"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0010","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinforma Oxf Engl"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0011","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cmb.2012.0021","article-title":"SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing","volume":"19","author":"Bankevich","year":"2012","journal-title":"J Comput Biol J Comput Mol Cell Biol"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0012","doi-asserted-by":"crossref","DOI":"10.1099\/mgen.0.000685","article-title":"Bakta: rapid and standardized annotation of bacterial genomes via alignment-free sequence identification","volume":"7","author":"Schwengers","year":"2021","journal-title":"Microb Genomics"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0013","unstructured":"Seemann, T. mlst: :id: scan contig files against PubMLST typing schemes. (accessed 05.12.23) https:\/\/github.com\/tseemann\/mlst."},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00483-19","article-title":"Validating the AMRFinder tool and resistance gene database by using antimicrobial resistance genotype-phenotype correlations in a collection of isolates","volume":"63","author":"Feldgarden","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/cid\/ciab888","article-title":"Progressive development of cefiderocol resistance in Escherichia coli during therapy is associated with an increase in blaNDM-5 copy number and gene expression","volume":"75","author":"Simner","year":"2022","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106635","article-title":"Cefiderocol heteroresistance in Klebsiella pneumoniae is linked to mutations in the siderophore receptor cirA and \u03b2-lactamase activities","volume":"60","author":"Moon","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0017","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciab511","article-title":"Rapid development of cefiderocol resistance in carbapenem-resistant Enterobacter cloacae during therapy is associated with heterogeneous mutations in the catecholate siderophore receptor cirA","volume":"74","author":"Klein","year":"2022","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0018","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/jac\/dkad004","article-title":"Rapid selection of a cefiderocol-resistant Escherichia coli producing NDM-5 associated with a single amino acid substitution in the CirA siderophore receptor","volume":"78","author":"Jousset","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0019","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10096-021-04397-x","article-title":"Co-resistance to ceftazidime-avibactam and cefiderocol in clinical isolates producing KPC variants","volume":"41","author":"Poirel","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0020","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/jac\/dkab304","article-title":"No in vitro activity of cefiderocol against OXA-427-producing enterobacterales","volume":"76","author":"Jacob","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0021","article-title":"BUSCO: assessing genome assembly and annotation completeness with single-copy orthologs","volume":"31","author":"Fa","year":"2015","journal-title":"Bioinforma Oxf Engl"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0022","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/bioinformatics\/btt086","article-title":"QUAST: quality assessment tool for genome assemblies","volume":"29","author":"Gurevich","year":"2013","journal-title":"Bioinforma Oxf Engl"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0023","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.50.2200926","article-title":"Increase in NDM-1 and NDM-1\/OXA-48-producing Klebsiella pneumoniae in Germany associated with the war in Ukraine, 2022","volume":"27","author":"Sandfort","year":"2022","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0024","article-title":"Development of cefiderocol resistance during treatment in Klebsiella pneumoniae","author":"Deroche","year":"2023","journal-title":"ECCMID"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0025","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1017\/ice.2022.161","article-title":"Comparing the activity of novel antibiotic agents against carbapenem-resistant Enterobacterales clinical isolates","volume":"44","author":"Tamma","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0026","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1089\/mdr.2022.0279","article-title":"In vitro activity of cefiderocol against meropenem-nonsusceptible gram-negative Bacilli with defined \u03b2-lactamase carriage: SIDERO-WT surveillance studies, 2014-2019","volume":"29","author":"Wise","year":"2023","journal-title":"Microb Drug Resist Larchmt N"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0027","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0029","article-title":"Occurrence of high levels of cefiderocol resistance in carbapenem-resistant Escherichia coli before its approval in China: a report from China CRE-Network","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0030","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00039-22","article-title":"Impact of acquired broad-spectrum \u03b2-lactamases on susceptibility to cefiderocol and newly developed \u03b2-lactam\/\u03b2-lactamase inhibitor combinations in Escherichia coli and Pseudomonas aeruginosa","volume":"66","author":"Poirel","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0031","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/mdr.2021.0095","article-title":"Defining baseline mechanisms of cefiderocol resistance in the enterobacterales","volume":"28","author":"Simner","year":"2022","journal-title":"Microb Drug Resist Larchmt N"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0032","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00084-22","article-title":"Emergence of high-level cefiderocol resistance in carbapenem-resistant Klebsiella pneumoniae from bloodstream infections in patients with hematologic malignancies in China","volume":"10","author":"Lan","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0033","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/ajcp\/aqab115","article-title":"Case report and genomic analysis of cefiderocol-resistant Escherichia coli clinical isolates","volume":"157","author":"Price","year":"2022","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0034","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.csbj.2023.01.004","article-title":"Molecular epidemiology and genomic insights into the transmission of carbapenem-resistant NDM-producing Escherichia coli","volume":"21","author":"Xu","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0035","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.19.2300209","article-title":"Rapid cross-border emergence of NDM-5-producing Escherichia coli in the European Union\/European Economic Area, 2012 to June 2022","volume":"28","author":"Linkevicius","year":"2023","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0036","doi-asserted-by":"crossref","first-page":"ofad276","DOI":"10.1093\/ofid\/ofad276","article-title":"An NDM-producing Escherichia coli clinical isolate exhibiting resistance to cefiderocol and the combination of Ceftazidime-Avibactam and Aztreonam: another step toward pan-\u03b2-lactam resistance","volume":"10","author":"Simner","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0037","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00269-20","article-title":"Novel insights and features of the NDM-5-producing Escherichia coli sequence type 167 high-risk clone","volume":"5","author":"Garcia-Fernandez","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0038","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1128\/AAC.00859-16","article-title":"Widespread dissemination of carbapenem-resistant Escherichia coli sequence type 167 strains harboring blaNDM-5 in clinical settings in China","volume":"60","author":"Huang","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0039","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02238-20","article-title":"Cross-border emergence of Escherichia coli producing the carbapenemase NDM-5 in Switzerland and Germany","volume":"59","author":"Chakraborty","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijantimicag.2018.10.007","volume":"53","author":"Kazmierczak","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0041","first-page":"178","article-title":"Global prevalence of cefiderocol non-susceptibility in enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia: a systematic review and meta-analysis","volume":"30","author":"Karakonstantis","year":"2024","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0042","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01582-20","article-title":"In vitro activity of cefiderocol, a siderophore cephalosporin, against multidrug-resistant gram-negative bacteria","volume":"64","author":"Mushtaq","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0043","doi-asserted-by":"crossref","first-page":"dlaa060","DOI":"10.1093\/jacamr\/dlaa060","article-title":"In vitro activity of the siderophore cephalosporin, cefiderocol, against molecularly characterized, carbapenem-non-susceptible gram-negative bacteria from Europe","volume":"2","author":"Longshaw","year":"2020","journal-title":"JAC-Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0044","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/AAC.01695-15","article-title":"In vitro antimicrobial activity of a siderophore cephalosporin, S-649266, against Enterobacteriaceae clinical isolates, including carbapenem-resistant strains","volume":"60","author":"Kohira","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jgar.2022.11.013","article-title":"In vitro activity of cefiderocol against clinically important carbapenem non-susceptible gram-negative bacteria from Saudi Arabia","volume":"32","author":"Alzayer","year":"2023","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0046","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04936-22","article-title":"In vitro activity of cefiderocol compared to other antimicrobials against a collection of metallo-beta-lactamase-producing gram-negative Bacilli from Southern Spain","volume":"11","author":"Delgado-Valverde","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2025.107553_bib0047","unstructured":"The European Committee on Antimicrobial Susceptibility Testing: Warning on cefiderocol susceptibility testing. https:\/\/www.eucast.org\/ast-of-bacteria\/warnings (accessed 27 February 2024)."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:48:55Z","timestamp":1758124135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925001104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0924857925001104"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107553","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Susceptibility to new antibiotics and genetic characterisation of carbapenemase-producing Enterobacterales: low activity of cefiderocol against NDM-producing isolates","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107553"}}